硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗 HLA-C 磁珠
蛋白与多肽

抗 HLA-C 磁珠

02AB00082

The Major Histocompatibility Complex, class I, C (HLA-C) protein is a cell membrane glycoprotein that plays an essential role in immune response by presenting peptides to cytotoxic T lymphocytes and interacting with natural killer (NK) cells through specific receptors like KIR. It consists of a heavy chain and a light beta-2 microglobulin chain, with structural regions encoded by eight exons. HLA-C expression is lower than related molecules HLA-A and HLA-B, regulated by polymorphisms and epigenetics, and its main function is to mediate immune recognition, including antiviral and cancer defenses. HLA-C's interaction with NK cells is crucial for the elimination of harmful cells, which also impacts organ transplant rejection and autoimmune disease modulation. Pathologically, variations in HLA-C are linked to diseases such as psoriasis, alopecia areata, preeclampsia, and certain cancers (e.g., nasopharyngeal, cervical, acute myeloid leukemia). The HLA-C/KIR signaling pathway modulates immune tolerance and cytotoxicity, influencing disease susceptibility and treatment outcomes.

Human
规格起售价
登录后可查看

技术参数

宿主
Mouse
靶点基因名
HLA-C
基因别名
HLAC
蛋白别名
major histocompatibility complex, class I, C; HLA-C(alpha-2 specific)
UniProt
P10321
物种
Human
应用
IP
Monoclonal
IgG1

产品详情

靶点名称
HLA-C(alpha-2 specific)
蛋白名称
major histocompatibility complex, class I, C
蛋白别名
HLA class I histocompatibility antigen; C alpha chain; HLA-C; HLA-Cw; Human leukocyte antigen C
靶点基因名
HLA-C
基因别名
HLAC
UniProt
P10321
来源物种
Homo sapiens (Human)
宿主物种
Mouse
物种反应性
Human
克隆性
Monoclonal
亚型
IgG1
配方
Supplied as solution in phosphate buffered saline containing 0.1% BSA and 0.02% sodium azide
剂型
Subject to solid-liquid separation upon standing; Mix thoroughly to ensure a consistent, homogeneous

免疫原核心序列

LEAARAAEQL

应用推荐稀释比备注
IP—50-100 μL/200 μg cell lysate

背景介绍

The Major Histocompatibility Complex, class I, C (HLA-C) protein is a cell membrane glycoprotein that plays an essential role in immune response by presenting peptides to cytotoxic T lymphocytes and interacting with natural killer (NK) cells through specific receptors like KIR. It consists of a heavy chain and a light beta-2 microglobulin chain, with structural regions encoded by eight exons. HLA-C expression is lower than related molecules HLA-A and HLA-B, regulated by polymorphisms and epigenetics, and its main function is to mediate immune recognition, including antiviral and cancer defenses. HLA-C's interaction with NK cells is crucial for the elimination of harmful cells, which also impacts organ transplant rejection and autoimmune disease modulation. Pathologically, variations in HLA-C are linked to diseases such as psoriasis, alopecia areata, preeclampsia, and certain cancers (e.g., nasopharyngeal, cervical, acute myeloid leukemia). The HLA-C/KIR signaling pathway modulates immune tolerance and cytotoxicity, influencing disease susceptibility and treatment outcomes.